Clearmind Medicine Depreciation & Amortization Growth & History (CMND)
Clearmind Medicine's depreciation and amortization was $49,369 for fiscal 2025.
View full Clearmind Medicine company overviewClearmind Medicine annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-10-31 | $49,369 | −$638 | −1.28% |
| 2024 | 2024-10-31 | $50,007 | $3,672 | +7.92% |
| 2023 | 2023-10-31 | $46,335 | $23,933 | +106.83% |
| 2022 | 2022-10-31 | $22,402 | $20,516 | +1087.80% |
| 2021 | 2021-10-31 | $1,886 | — | — |
Clearmind Medicine quarterly depreciation and amortization
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-04-30 | $13,901 | $1,931 | +16.13% |
| Q1 2026 | 2026-01-31 | $13,328 | — | — |
| Q4 2025 | 2025-10-31 | $12,838 | — | — |
| Q3 2025 | 2025-07-31 | $12,523 | — | — |
| Q2 2025 | 2025-04-30 | $11,970 | — | — |
Clearmind Medicine depreciation and amortization trends
Between the periods ended 2021-10-31 and 2025-10-31, Clearmind Medicine's depreciation and amortization increased from $1,886 to $49,369, a change of $47,483. The latest reported quarter, Q2 2026, shows $13,901.
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Clearmind Medicine source filings ↗